CERVETTO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 7.534
Totale 7.534
Nazione #
IT - Italia 7.534
Totale 7.534
Città #
Genova 5.068
Genoa 1.385
Rapallo 1.057
Bordighera 23
Vado Ligure 1
Totale 7.534
Nome #
1,2-dihydro-2-oxo-pyridine-3-carboxamide derivative as multi-target modulator of endocannabinoid system for an innovative therapeutic approach in multiple sclerosis 248
A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes 170
A2A-D2 heteromers on striatal astrocytes: Biochemical and biophysical evidence 151
Calcium-permeable AMPA receptors trigger vesicular glutamate release from Bergmann gliosomes 146
Carbenoxolone inhibits volume-regulated anion conductance in cultured rat cortical astroglia 143
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 142
Inhibition of presynaptic release-facilitatory kainate autoreceptors by extracellular cyclic GMP 138
Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals. 137
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex. 137
5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices 136
Nitric oxide-evoked cGMP production in Purkinje cells in rat cerebellum: an immunocytochemical and pharmacological study 131
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1 129
Near infrared laser photons induce glutamate release from cerebrocortical nerve terminals 129
Expression of PINK1 in the brain, eye and ear of mouse during embryonic development 125
Perinatal hypoxia affects neuronal and glial P2X7 receptor activity in neonatal and adult rat 124
Glutamate Excitotoxicity Linked to Spermine Oxidase Overexpression 124
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 123
Astrocyte-dependent vulnerability to excitotoxicity in spermine oxidase-overexpressing mouse 122
In vitro modulation of gamma amino butyric acid (GABA) receptor expression by bone marrow stromal cells 117
Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: Control by presynaptic 5-HT1D receptors 114
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein. 111
Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X(7)-Evoked Glutamate Release 110
Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation 109
Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes 108
Cochlear cells: P2X7 receptor is a candidate for glutamate release 107
Identification of PINK1 in the brain, eye and ear of mouse during embryonic development. 106
In vitro homogeneous and heterogeneous interconnected neuronal cultures: exploring expressed dynamics and functional connectivity 103
Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals 102
Extracellular cGMP control of kainate receptor activation in rat cerebellar astrocyte processes 97
GABAA and strychnine-sensitive glycine receptors modulate NMDA-evoked acetylcholine release from rat spinal motoneurons: a possible role in neuroprotection 97
Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes. 96
Neuronal cultures coupled to Micro-Electrode Arrays as a new tool for neurotoxicological evaluation 94
Motor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism 87
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 84
P2X7 presynaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release 82
Ca2+ permeable AMPA receptors are coupled to vesicular glutamate release from Bergmann glia processes 79
Exosomes from astrocyte processes: Signaling to neurons 75
Ca2+ permeable AMPA receptors evoke glutamate release from Bergmann glia processes 71
Presynaptic P2X7 receptor function following perinatal hypoxia 70
Purified glial processes isolated from rat cerebellum are endowed with Ca2+ permeable AMPA receptors 70
P2X7 antagonism in a mouse model of Amyotrophic Lateral Sclerosis: gender dependency 70
The C-terminal domain is required for the P2X7 receptor functioning as a route for glutamate release 70
NO-cGMP pathway controls network activity in dissociated cortical neurons coupled to Micro-Electrode Arrays 69
P2X7 receptor as a candidate for glutamate release in cochlear cells 67
A2A-D2 receptor-receptor interaction in striatal astrocyte processes: homocysteine modulation of glutamate release 67
Extracellular cGMP modulates presynaptic kainate receptors 65
In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOd1/G93A(+) mouse model of amyotrophioc lateral sclerosis. 65
Calmidazolium a selective inhibitor of exocytotic glutamate release evoked by P2X7 receptor activation 62
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 60
Role of spermine oxidase in modulation of glutamate receptors and transporters during excitotoxic stress 59
Biochemical and biophysical evidence for the A2A-D2 heteroreceptors in striatal astrocytes 59
Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes 58
IL-1 alpha and modulation of spinal glutamate release: protection against oxaliplatin-induced neuropathic pain 58
A2A-D2 heterodimers control glutamate release from striatal astrocytes 58
Release regulating mGlu2-preferring and mGlu3 preferring autoreceptors in CNS 57
NO-cGMP pathway controls network activity in dissociated cortical neurons coupled to Micro-Electrode Arrays 56
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 56
Modulation of kainate receptors by extracellular cGMP 55
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2-preferring and mGlu3-preferring autoreceptors and their role in demyelinating disease. 55
Gamma amino butyric acid (GABA) receptors in induced neuron-like Bone Marrow Stromal Cells 54
Increased vulnerability to excitotoxicity in spermine oxidase overexpressing mouse: astrocyte-dependency 54
Striatal astrocytic processes and glutamate release: effects of homocysteine and A2A-D2 receptor-receptor interaction 54
Astrocyte-dependent susceptibility to excitotoxicity in spermine oxidase overexpressing mouse 53
Vulnerability to seizures and astrocytes: a model mouse of deregulated polyamine metabolism 53
A2A-D2 heterodimers on striatal astrocytes: effects of homocysteine 52
A2A-D2 heterodimers on striatal astrocytes: biochemical and biophysical evidences 52
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2/3 autoreceptors in the spinal cord. 52
Striatal glutamatergic transmission: astrocytic A2A-D2 receptor-receptor interaction and homocysteine 50
Bergmann glial processes: Ca2+ permeable AMPA receptors are coupled to vesicular glutamate release 50
Ca2+ permeable AMPA receptors are present on purified glial processes isolated from rat cerebellum 49
Chemotherapy-induced neuropathic pain: P2X7 receptor and recruitment of pannexin1 49
In vitro neurotoxicity testing: Functional neuron-specific endpoints 49
Susceptibility to excitotoxicity and epileptic seizures in spermine oxidase overexpressing mouse: astrocyte dependency 48
Gender-dependent effect of P2X7 antagonism in a mouse model of ALS 45
Heterodimer of A2A and Oxytocin Receptors Regulating Glutamate Release in Adult Striatal Astrocytes 44
Native A2A-D2 heterodimers: modulation of glutamate release from striatal astrocyte processes 43
Native A2A-D2 receptor-receptor interaction in striatal astrocyte processes: modulation of glutamate release 43
A2A-D2 heteromerization on striatal astrocytes: evidence and modulation of glutamate release 43
Bioeconomia e Ricerca Farmacologica 42
A2A-D2 heterodimers on striatal astrocytes: effects of homocysteine 42
A2A-D2 heterodimers on striatal astrocytes 41
IL-1a evokes protective signals against oxaliplatin neurotoxicity by a spinal modulation of glutamate release 41
Reactive astrocytosis in a mouse model of chronic polyamine catabolism activation 40
Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate release in mouse cortex and spinal cord 39
Reti neuronali su MultiElectrode Arrays (MEAs): metodo alternativo per la valutazione di neurotossicità 39
Oxaliplatin neuropathic pain: involvement of the P2X7 receptor and recruitment of pannexin1 38
Seizure vulnerability linked to astrocytes: a model mouse of deregulated polyamine metabolism 37
null 35
Native A2A-D2 heterodimers modulate glutamate release from striatal astrocyte processes 35
Transgenic Mouse Overexpressing Spermine Oxidase in Cerebrocortical Neurons: Astrocyte Dysfunction and Susceptibility to Epileptic Seizures 34
Striatal astrocytes: functional evidence of A2A-D2 heterodimerization and modulation of glutamate release 33
Striatal astrocytes and glutamate release: A2A-D2 receptor-receptor interaction 32
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 31
Striatal astrocytes: biochemical and biophysical evidence of A2A-D2 heterodimerization 30
Vesicular glutamate release from feeder-free hiPSC-derived neurons 27
Signals from astrocytes to neurons: exosomes released from astrocytic processes 27
Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing 26
Astrocyte signalling to neurons through exosomes 25
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 23
Receptor–receptor interactions and glial cell functions with a special focus on g protein-coupled receptors 23
Totale 7.487
Categoria #
all - tutte 24.514
article - articoli 14.856
book - libri 0
conference - conferenze 9.658
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.701 89 40 56 76 114 176 265 97 115 384 244 45
2020/2021578 42 35 49 22 42 44 32 56 65 111 43 37
2021/20221.199 32 89 75 102 68 79 48 281 72 124 59 170
2022/20231.318 141 92 43 101 204 178 10 90 213 37 181 28
2023/20241.119 36 118 24 139 79 197 98 57 50 70 103 148
2024/202577 77 0 0 0 0 0 0 0 0 0 0 0
Totale 7.782